Healthy Skepticism Library item: 3502

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Re: the promotion of co-dergocrine
1987 Feb;

Abstract:

Sandoz is making claims about co-dergocrine (Hydergine) for cerebrovascular disease which do not appear to be in accord with the scientific literature.

Keywords:
*analysis/developing countries/co-dergocrine/Hydergine/ neurologic drugs/Sandoz/cerebrovascular disease/MaLAM/Medical Lobby for Appropriate Marketing/ quality of information/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES/PROMOTION IN SPECIFIC THERAPEUTIC AREAS: NEUROLOGIC DISEASES